Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark James Daniel currently holds 63,000 shares of ATOSSA THERAPEUTICS, INC. (ATOS), valued at approximately $0. This represents their equity stake as Chief Financial Officer.
Based on SEC Form 4 filings, Mark James Daniel has been a net neutral trader of ATOS stock. They have purchased $0 and sold $0 worth of shares.
Mark James Daniel's most recent insider trade was on Mar 26, 2026, when they sold 63,000 shares at $0.00 per share.
Mark James Daniel serves as Chief Financial Officer at ATOSSA THERAPEUTICS, INC. (ATOS). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Mark James Daniel holds the position of Chief Financial Officer at ATOSSA THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Mark James Daniel has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Mark James Daniel was on Mar 26, 2026, when they purchased $0 worth of ATOS shares. This transaction involved 63,000 shares at N/A per share.
Mark James Daniel currently owns 63,000 shares of ATOSSA THERAPEUTICS, INC. (ATOS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark James Daniel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark James Daniel has 1 Form 4 filings on record as an insider at ATOSSA THERAPEUTICS, INC..
Set alerts for Mark James Daniel and 40,000+ other insiders.